Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$21.94 - $42.51 $2.93 Million - $5.68 Million
-133,499 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$36.09 - $53.79 $146,417 - $218,226
-4,057 Reduced 2.95%
133,499 $5.5 Million
Q3 2021

Nov 10, 2021

SELL
$35.62 - $52.97 $495,901 - $737,448
-13,922 Reduced 9.19%
137,556 $6.39 Million
Q2 2021

Aug 13, 2021

SELL
$32.94 - $56.62 $551,020 - $947,139
-16,728 Reduced 9.94%
151,478 $6.06 Million
Q1 2021

May 14, 2021

BUY
$44.47 - $81.38 $1.59 Million - $2.91 Million
35,733 Added 26.97%
168,206 $9.04 Million
Q4 2020

Feb 02, 2021

BUY
$32.49 - $61.88 $440,986 - $839,897
13,573 Added 11.42%
132,473 $6.48 Million
Q3 2020

Nov 05, 2020

BUY
$26.73 - $35.67 $473,121 - $631,359
17,700 Added 17.49%
118,900 $3.86 Million
Q2 2020

Aug 12, 2020

SELL
$19.49 - $28.11 $102,575 - $147,942
-5,263 Reduced 4.94%
101,200 $2.62 Million
Q1 2020

May 12, 2020

SELL
$16.13 - $30.17 $809,726 - $1.51 Million
-50,200 Reduced 32.04%
106,463 $2.59 Million
Q4 2019

Jan 27, 2020

SELL
$20.78 - $29.99 $678,591 - $979,353
-32,656 Reduced 17.25%
156,663 $4.37 Million
Q3 2019

Oct 31, 2019

BUY
$23.87 - $30.93 $605,104 - $784,075
25,350 Added 15.46%
189,319 $4.54 Million
Q2 2019

Aug 15, 2019

SELL
$22.1 - $28.56 $190,767 - $246,529
-8,632 Reduced 5.0%
163,969 $4.68 Million
Q1 2019

May 03, 2019

BUY
$12.0 - $25.76 $245,724 - $527,487
20,477 Added 13.46%
172,601 $4.32 Million
Q4 2018

Feb 08, 2019

BUY
$9.15 - $14.85 $89,889 - $145,886
9,824 Added 6.9%
152,124 $1.91 Million
Q3 2018

Nov 13, 2018

SELL
$9.55 - $12.64 $60,165 - $79,632
-6,300 Reduced 4.24%
142,300 $1.36 Million
Q3 2017

Nov 15, 2017

BUY
$7.81 - $8.77 $1.16 Million - $1.3 Million
148,600
148,600 $1.3 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.97B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.